BR9506484A - Neuraminidase recombinate seu vetor processo para sua manufatura e uso como vacina contra influenza - Google Patents
Neuraminidase recombinate seu vetor processo para sua manufatura e uso como vacina contra influenzaInfo
- Publication number
- BR9506484A BR9506484A BR9506484A BR9506484A BR9506484A BR 9506484 A BR9506484 A BR 9506484A BR 9506484 A BR9506484 A BR 9506484A BR 9506484 A BR9506484 A BR 9506484A BR 9506484 A BR9506484 A BR 9506484A
- Authority
- BR
- Brazil
- Prior art keywords
- recombines
- neuraminidase
- manufacture
- influenza vaccine
- process vector
- Prior art date
Links
- 102000005348 Neuraminidase Human genes 0.000 title 1
- 108010006232 Neuraminidase Proteins 0.000 title 1
- 229960003971 influenza vaccine Drugs 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01018—Exo-alpha-sialidase (3.2.1.18), i.e. trans-sialidase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
- C12N2710/14141—Use of virus, viral particle or viral elements as a vector
- C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Plant Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL9400045A NL9400045A (nl) | 1994-01-11 | 1994-01-11 | Influenza vaccin. |
| EP94200159 | 1994-01-24 | ||
| PCT/BE1995/000002 WO1995018861A1 (en) | 1994-01-11 | 1995-01-06 | Influenza vaccine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9506484A true BR9506484A (pt) | 1997-10-07 |
Family
ID=26136020
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9506484A BR9506484A (pt) | 1994-01-11 | 1995-01-06 | Neuraminidase recombinate seu vetor processo para sua manufatura e uso como vacina contra influenza |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US5962298A (pt) |
| EP (1) | EP0733113B1 (pt) |
| JP (2) | JPH09511381A (pt) |
| CN (1) | CN1149888A (pt) |
| AU (1) | AU1308495A (pt) |
| BR (1) | BR9506484A (pt) |
| CA (1) | CA2180965C (pt) |
| PT (1) | PT733113E (pt) |
| WO (1) | WO1995018861A1 (pt) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6485729B1 (en) * | 1993-09-13 | 2002-11-26 | Protein Sciences Corporation | Neuraminidase-supplemented compositions |
| CA2180965C (en) * | 1994-01-11 | 2010-05-11 | Tom Maria Deroo | Influenza vaccine |
| US7157089B1 (en) * | 1996-11-26 | 2007-01-02 | Stressgen Biotechnologies Corporation | Immune responses using compositions containing stress proteins |
| US6289147B1 (en) | 1999-11-01 | 2001-09-11 | Bbv Design Bv | Passband flattening of a phasar |
| US20040091503A1 (en) * | 2002-08-20 | 2004-05-13 | Genitrix, Llc | Lectin compositions and methods for modulating an immune response to an antigen |
| US7468187B2 (en) | 2005-10-18 | 2008-12-23 | Iowa State University Research Foundation, Inc. | Canine influenza virus and related compositions and methods of use |
| CN104826102A (zh) * | 2006-02-02 | 2015-08-12 | 全球免疫股份有限公司 | 用于诱导免疫应答的基于酵母的疫苗 |
| CA2638760A1 (en) * | 2006-03-07 | 2007-09-13 | Vaxinnate Corporation | Compositions that include hemagglutinin, methods of making and methods of use thereof |
| JP2009534303A (ja) | 2006-03-24 | 2009-09-24 | ノバルティス ヴァクシンズ アンド ダイアグノスティクス ゲーエムベーハー アンド カンパニー カーゲー | 冷蔵しないインフルエンザワクチンの保存 |
| GB0614460D0 (en) | 2006-07-20 | 2006-08-30 | Novartis Ag | Vaccines |
| KR100850545B1 (ko) * | 2007-10-30 | 2008-08-05 | 주식회사 에니멀제네틱스 | 신규한 개 인플루엔자 바이러스 및 이의 백신 |
| GB0810305D0 (en) | 2008-06-05 | 2008-07-09 | Novartis Ag | Influenza vaccination |
| CN104080475A (zh) | 2008-04-18 | 2014-10-01 | 法克斯因内特公司 | 鞭毛蛋白的缺失突变体以及使用方法 |
| EP2278997B1 (en) | 2008-04-21 | 2016-08-10 | Nanobio Corporation | Nanoemulsion influenza vaccine |
| EP2168987A1 (en) * | 2008-09-22 | 2010-03-31 | Mucosis B.V. | Multifunctional linker protein containing an antibody against hemagglutinin, a conserved influenza antigen and an immunostimulating carrier binding domain |
| USH2284H1 (en) | 2009-04-27 | 2013-09-03 | Novartis Ag | Vaccines for protecting against influenza |
| JP5823379B2 (ja) | 2009-05-29 | 2015-11-25 | ノバルティス アーゲー | インフルエンザウイルスヘマグルチニンについてのアッセイ |
| CA2767392C (en) | 2009-07-06 | 2017-03-14 | Variation Biotechnologies, Inc. | Methods for preparing vesicles and formulations produced therefrom |
| US9907746B2 (en) | 2009-07-06 | 2018-03-06 | Variation Biotechnologies, Inc. | Methods for preparing vesicles and formulations produced therefrom |
| SG178904A1 (en) | 2009-09-10 | 2012-04-27 | Novartis Ag | Combination vaccines against respiratory tract diseases |
| CA3153553A1 (en) * | 2009-12-28 | 2011-07-28 | Sanofi Vaccine Technologies, S.A.S. | Methods of producing heterologous proteins comprising membrane domains in microalgal extracellular bodies |
| HUE030724T2 (en) | 2010-04-09 | 2017-06-28 | Univ Utrecht Holding Bv | Recombinant multimer influenza proteins |
| CA2801149A1 (en) | 2010-06-01 | 2011-12-08 | Novartis Ag | Concentration of vaccine antigens without lyophilization |
| PL2575873T3 (pl) | 2010-06-01 | 2016-06-30 | Novartis Ag | Zatężanie i liofilizacja antygenów szczepionkowych grypy |
| CA2840079C (en) | 2010-07-06 | 2018-07-03 | Variation Biotechnologies Inc. | Compositions and methods for treating influenza |
| CA2808965C (en) | 2010-08-20 | 2020-01-07 | Novartis Ag | Soluble needle arrays for delivery of influenza vaccines |
| AU2012205315B2 (en) | 2011-01-13 | 2017-05-04 | Variation Biotechnologies, Inc. | Methods for preparing vesicles and formulations produced therefrom |
| WO2012097346A1 (en) | 2011-01-13 | 2012-07-19 | Variation Biotechnologies, Inc. | Compositions and methods for treating viral infections |
| CA2840982C (en) | 2011-07-06 | 2022-06-07 | Vira BITKO | Human respiratory syncytial virus vaccine |
| US10206996B2 (en) | 2011-08-22 | 2019-02-19 | Nanobio Corporation | Herpes simplex virus nanoemulsion vaccine |
| US20140328876A1 (en) | 2011-11-18 | 2014-11-06 | Variation Biotechnologies Inc. | Synthetic derivatives of mpl and uses thereof |
| US20140335507A1 (en) | 2011-12-12 | 2014-11-13 | Novartis Ag | Assays for influenza virus hemagglutinins |
| EP2802353A4 (en) | 2012-01-12 | 2015-12-02 | Variation Biotechnologies Inc | COMPOSITIONS AND METHOD FOR THE TREATMENT OF VIRUS INFECTIONS |
| US20150079077A1 (en) | 2012-01-27 | 2015-03-19 | Variation Biotechnologies, Inc. | Methods and compositions for therapeutic agents |
| WO2013185177A1 (en) * | 2012-06-12 | 2013-12-19 | Csl Limited | Influenza vaccine |
| US8932598B2 (en) | 2012-08-28 | 2015-01-13 | Vaxinnate Corporation | Fusion proteins and methods of use |
| ES2924721T3 (es) * | 2014-05-27 | 2022-10-10 | Us Health | Trímeros de la región del tallo de la hemaglutinina estabilizada de la influenza y usos de los mismos |
| MX2023012554A (es) | 2018-12-12 | 2023-11-08 | Cambridge Tech Llc | Vacuna universal contra la gripe. |
| WO2024078631A1 (zh) * | 2022-10-14 | 2024-04-18 | 吴夙钦 | 流感病毒神经氨酸酶突变体、编码流感病毒神经氨酸酶突变体的核酸分子、包含流感病毒神经氨酸酶突变体的疫苗组合物及流感病毒神经氨酸酶突变体用于制备流感病毒疫苗组合物的用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6100064A (en) * | 1984-04-06 | 2000-08-08 | Chiron Corporation | Secreted viral proteins useful for vaccines and diagnostics |
| US4861864A (en) * | 1985-05-14 | 1989-08-29 | Albert Einstein College of Medicine of Yeshiva University (a Div. of Yeshiva University) | Rotavirus antigens |
| CA2180965C (en) * | 1994-01-11 | 2010-05-11 | Tom Maria Deroo | Influenza vaccine |
-
1995
- 1995-01-06 CA CA2180965A patent/CA2180965C/en not_active Expired - Lifetime
- 1995-01-06 CN CN95192014A patent/CN1149888A/zh active Pending
- 1995-01-06 PT PT95904370T patent/PT733113E/pt unknown
- 1995-01-06 JP JP7518230A patent/JPH09511381A/ja active Pending
- 1995-01-06 BR BR9506484A patent/BR9506484A/pt not_active Application Discontinuation
- 1995-01-06 US US08/669,496 patent/US5962298A/en not_active Expired - Lifetime
- 1995-01-06 EP EP95904370A patent/EP0733113B1/en not_active Expired - Lifetime
- 1995-01-06 AU AU13084/95A patent/AU1308495A/en not_active Abandoned
- 1995-01-06 WO PCT/BE1995/000002 patent/WO1995018861A1/en active IP Right Grant
-
1999
- 1999-02-25 US US09/257,578 patent/US6605457B1/en not_active Expired - Lifetime
-
2002
- 2002-02-20 US US10/079,177 patent/US7468259B2/en not_active Expired - Lifetime
-
2006
- 2006-02-03 JP JP2006027285A patent/JP4551338B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| AU1308495A (en) | 1995-08-01 |
| CA2180965C (en) | 2010-05-11 |
| EP0733113B1 (en) | 2007-05-02 |
| JP4551338B2 (ja) | 2010-09-29 |
| CA2180965A1 (en) | 1995-07-13 |
| CN1149888A (zh) | 1997-05-14 |
| US5962298A (en) | 1999-10-05 |
| WO1995018861A1 (en) | 1995-07-13 |
| JP2006193527A (ja) | 2006-07-27 |
| US7468259B2 (en) | 2008-12-23 |
| US20030129197A1 (en) | 2003-07-10 |
| PT733113E (pt) | 2007-08-10 |
| EP0733113A1 (en) | 1996-09-25 |
| JPH09511381A (ja) | 1997-11-18 |
| US6605457B1 (en) | 2003-08-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9506484A (pt) | Neuraminidase recombinate seu vetor processo para sua manufatura e uso como vacina contra influenza | |
| BR9501770A (pt) | Uso de um composto,composto,formulação farmacêutica e processo para preparar um composto | |
| PT793484E (pt) | Adjuvante para composicao de vacina | |
| BR9503033A (pt) | Estrutura absorvente; produto absorvente descartável e processo para preparar estrutura absorvente | |
| PT1003478E (pt) | Preparacoes aquosas de aerossol contendo macromoleculas biologicamente activas e processo para a preparacao dos respectivos aerossois | |
| BR9909313B1 (pt) | Sistema terapêutico transdérmico, processo para a preparação de um sistema terapêutico transdérmico, e, produto | |
| EP0755372A4 (en) | INHIBITORS OF THE NEURAMINIDASE OF THE FLU VIRUS AND METHOD FOR THE PRODUCTION AND USE THEREOF | |
| DE69800383D1 (de) | Influenza Vaccine | |
| PT1218341E (pt) | Derivados de sulfonilcarboxamidas, processo para a sua preparacao e sua utilizacao como medicamentos | |
| BR0017030B1 (pt) | derivados de tiazolilamida, processo para sua preparação, composição farmacêutica que os compreende e uso dos mesmos | |
| BR0015939B1 (pt) | Sistema terapêutico transdérmico com estabilidade aperfeiçoada e processo para a sua preparação | |
| BR9204931A (pt) | Oligodesoxirribonucleotideos de origem natural,processo para a obtencao dos mesmos,seus usos e composicoes farmaceuticas | |
| BR9103036A (pt) | Composto,formulacao farmaceutica e processo para a preparacao do composto | |
| BR9504463A (pt) | Processo para preparaçao de lipossomas de quetoprofeno e preparaçoes farmacêuticas | |
| PT854879E (pt) | Novos derivados de 5-o-desosaminil-6-o-metil-eritronolida a, processo para a sua preparacao e sua aplicacao a preparacao de produtos biologicamente activos | |
| PT839138E (pt) | Processo para a preparacao de 3-hidroxipirazois substituidos em n | |
| BR9505962A (pt) | Suspensão farmacêutica aquosa e processo para sua preparação | |
| PT1098891E (pt) | Aminas tiazolidin-2-ilideno policiclicas processo para a sua preparacao e sua utilizacao como medicamento | |
| BR9003300A (pt) | Processo de remolho sustentato enzimaticamente,para peles e pelos | |
| BR9404225A (pt) | Formulação de substância ativa, aplicação, composições, medicamentos e processo para a preparação das formulações | |
| BR9708979A (pt) | Complexo imunogénico utilização do mesmo vacina processo para a preparação de um complexo imunogenico e utilização de uma proteína | |
| PT1189932E (pt) | Derivados de echinocandina processo para a sua preparacao e sua utilizacao como agentes antifungicos | |
| PT1053224E (pt) | Bifenilsulfonilcianamida, processo para a sua preparacao e sua utilizacao como medicamento | |
| BR9106188A (pt) | Novos derivados p-substituidos de fenil-4-oxibutano amina,processo para sua preparacao e composicoes farmaceuticas contendo os mesmos | |
| PT1100775E (pt) | Benzenossulfonilureias e benzenossulfoniltiureias 2,5-substituidas processo para a sua preparacao sua utilizacao e preparados farmaceuticos que as contem |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B07B | Technical examination (opinion): publication cancelled [chapter 7.2 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: DESSA FORMA, ACORDO COM O ART. 37, INDEFIRO O PRESENTE PEDIDO COM BASE NOS ARTS. 8O, 11, 13 E 25 DA LPI EM VIGOR. |
|
| B12B | Appeal against refusal [chapter 12.2 patent gazette] |